|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1246582105 |
| 003 |
OCoLC |
| 005 |
20241006213017.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
210417s2021 si o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d N$T
|d OCLCF
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|d TMA
|d OCLCQ
|d SXB
|
| 020 |
|
|
|a 9811478430
|
| 020 |
|
|
|a 9789811478437
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1246582105
|
| 050 |
|
4 |
|a RM301.4
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Atta-ur-Rahman.
|
| 245 |
1 |
0 |
|a Frontiers in Clinical Drug Research - Anti-Cancer Agents
|h [electronic resource].
|
| 260 |
|
|
|a Singapore :
|b Bentham Science Publishers,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (231 p.).
|
| 490 |
1 |
|
|a Frontiers in Clinical Drug Research - Anti-Cancer Agents Ser.
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 650 |
|
0 |
|a Biopharmaceutics.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
0 |
|a Medical innovations.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
|
7 |
|a Biopharmaceutics
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
| 650 |
|
7 |
|a Medical innovations
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|
| 758 |
|
|
|i has work:
|a Frontiers in Clinical Drug Research - Anti-Cancer Agents (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXDKVB9kKRGD6D3xcGvQWP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Atta-ur-Rahman
|t Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 6
|d Singapore : Bentham Science Publishers,c2021
|z 9789811478413
|
| 830 |
|
0 |
|a Frontiers in Clinical Drug Research - Anti-Cancer Agents Ser.
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=6549244
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|